News
HST Collects relevant news from a variety of sources, for your convenience. Select a story from below, or use our search feature to find stories of interest.

WHO releases list of recommended AIDS drugs
by IRIN
2002-03-27

In a move that could reduce the price of AIDS drugs for poor countries, the World Health Organisation (WHO) released its first list of safe HIV-related medicines on Wednesday. The list released this week includes 11 antiretroviral drugs and five drugs for opportunistic infections. Of the total, 26 came from major manufacturers and 10 were from leading Indian generic drug producer, Cipla. The company was one of the first generic manufacturers to offer cheaper AIDS drugs to African governments. The decision means that there will be price competition among manufacturers of important antiretroviral treatments. Cipla products include nevirapine, zidovudine (AZT), and lamivudine (3TC), which make up a common AIDS cocktail. International humanitarian organisation, Medecines sans frontieres (MSF), welcomed the involvement of generic manufacturers but expressed concerns about the process used. MSF regrets that the WHO prequalification process was started too late and that it has been so slow, considering that the first expressions of interest from producers were received in December 2000, the organisation said in a statement. WHO was still reviewing other products and suppliers and would add them to the list once they had met the set standards, they added. The absence of essential drugs such as fluconazole - used for treating thrush and cryptococal meningitis - was also a concern, as this would give users a false impression about their quality, the MSF statement added. To access the list: http://www.who.int/medicines/organization/qsm/activities/pilotproc/suppliers.doc (Source: IRIN - Plus News, 22 March 2002)

 In a move that could reduce the price of AIDS drugs for poor countries, the World Health Organisation (WHO) released its first list of safe HIV-related medicines on Wednesday.

We hope this project will help HIV positive people gain greater access to affordable HIV medicines of good quality, Dr Peter Piot, director of UNAIDS, said in a joint WHO and UNAIDS press release.

The list released this week includes 11 antiretroviral drugs and five drugs for opportunistic infections. Of the total, 26 came from major manufacturers and 10 were from leading Indian generic drug producer, Cipla. The company was one of the first generic manufacturers to offer cheaper AIDS drugs to African governments.

The decision means that there will be price competition among manufacturers of important antiretroviral treatments. Cipla products include nevirapine, zidovudine (AZT), and lamivudine (3TC), which make up a common AIDS cocktail.

International humanitarian organisation, Medecines sans frontieres (MSF), welcomed the involvement of generic manufacturers but expressed concerns about the process used. MSF regrets that the WHO prequalification process was started too late and that it has been so slow, considering that the first expressions of interest from producers were received in December 2000, the organisation said in a statement.

This is the beginning of an ongoing process, Daniela Bagozzi, communications officer for the health, technology and pharmaceuticals division of WHO, told PlusNews on Friday. WHO was still reviewing other products and suppliers and would add them to the list once they had met the set standards, she added.

The absence of essential drugs such as fluconazole - used for treating thrush and cryptococal meningitis - was also a concern, as this would give users a false impression about their quality, the MSF statement added.

But we are really supportive of this project because we want the maximum number of patients to benefit from these drugs, Carmen Perez-Casas pharmaceutical coordinator for MSF, told PlusNews.

To access the list:

http://www.who.int/medicines/organization/qsm/activities/pilotproc/suppliers.doc

Source: IRIN - Plus News, 22 March 2002

Keywords	This Item is associated with the Following Keywords: .
You Can Comment on this Item, or View other people's Comments
Easy Print  Email to a friend

	Related News
	Generic AIDS drugs to be re-evaluated (2004-08-17) More offers to supply AIDS drugs at cheaper prices (2001-03-09) Firm offers to sell HIV drugs at low price (2001-02-09) Generic anti-AIDS drugs withdrawn from WHO list (2004-11-11) WHO removes three Ranbaxy antiretrovirals from prequalification list due to failings in research procedures (2004-08-06)

	Related Publications
	Essential Drugs List Programme (2000-06-08) Introducing Antiretroviral Therapy (ART) on a Large Scale: Hope and Caution (2004-03-31) Standard Treatment Guidelines and Essential Drugs List - Primary Health Care 2003 Edition (2004-11-03) Drug Pricing (2001-03-14) Providing HIV Services including Antiretroviral Therapy at Primary Health Care Clinics in Resource-Poor Settings: The experience from Khayelitsha (2004-05-25)

	Related Health Statistics
	Percentage of facilities out of stock: STI medicines (2004-05-14) Primary drug of abuse as % of all drugs of abuse (2007-05-21) Proportion of population with sustainable access to an improved water source (2005-09-07) AIDS orphans (2005-04-20) Percentage of deaths due to AIDS (2005-04-20)

	Related Events
	Training Course on Drug and Therapeutic Committees (2001-10-18) International Conference on Improving Use of Medicines (ICIUM2004) (2004-03-30) International HIV/AIDS Treatment Education and Advocacy Summit (2000-03-13) HIV/AIDS Stigma Conference, 2006 (2006-01-24) The National Health Care Quality Month Seminar (2004-11-24)

	Related links
	MSF Campaign for Access to Essential Medicines Essential Drugs and Medicines Policy (EDM) Essentialdrugs.org Medicines for Malaria Venture INRUD: International Network for Rational Use of Drugs

	Related Content
	Summary Bulletin 6 - DHS-LG Discussion List (2004-07-16) The Treatment Monitor (2004-03-31) Summary Bulletin 10 (August) - DHS-LG Discussion List (2004-07-16) Electronic Discussion Lists (2004-05-03) Treatment Monitor: Sexual and Reproductive Intentions (2008-02-14)